Mitochondrial Composition for Refractory Seizure Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current anti-epileptic drugs fail to control seizures in 30% of patients, and dietary regimens like the ketogenic diet are not feasible for all due to compliance issues and side effects, highlighting the need for alternative treatments that target mitochondrial function to manage refractory seizures.
Innovation Solution
A composition comprising ascorbic acid, vitamin E, and pyruvate, administered to restore mitochondrial function in seizure-genic brain regions, which can be administered orally or intravenously, offering an alternative to traditional anticonvulsant medications and dietary treatments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current anti-epileptic drugs are administered, then seizure control is achieved in 70% of patients, but 30% of patients remain untreated (refractory seizures)
Solution Approach 1:
The patent changes the therapeutic parameter from ion channel/receptor modulation to mitochondrial function restoration. By administering compositions containing mitochondrial substrates (pyruvate, ketone bodies) and antioxidants, the treatment targets a different physiological parameter that is effective for refractory seizures not responsive to conventional medications.
2Reliability
If ketogenic diet is administered, then seizure control is achieved, but compliance issues and side effects limit its feasibility
Solution Approach 1:
The patent extracts the therapeutic mechanism of the ketogenic diet (providing alternative mitochondrial substrates) from the complex dietary regimen. By administering purified mitochondrial substrates and antioxidants as a pharmaceutical composition, the treatment isolates the effective component while eliminating the compliance burden and side effects of strict dietary restriction.
3Reliability
If mitochondrial function is restored using composition, then seizure frequency and intensity are reduced, but the treatment mechanism differs from conventional approaches
Solution Approach 1:
The patent introduces mitochondrial substrates (pyruvate, ketone bodies) and antioxidants as intermediary substances that mediate between the administered composition and the therapeutic effect. These intermediaries restore mitochondrial function, which in turn reduces neuronal hyperexcitability and seizure activity, providing a bridge between the treatment and the desired outcome.
Data Source
AI summary
A method and a composition are utilized to affect mitochondrial functions on a seizure-genic brain region. In one aspect, the disclosure comprises methods of treating seizures. Seizures are a transient symptom of abnormal excessive or synchronous neuronal activity in the brain. Seizures may manifest as a wild thrashing movement, a brief loss of awareness, an alteration in mental state, tonic or clonic movements, convulsions, a full body slump, and various other psychic symptoms such as déjà vu or jamais vu. Recurrent, unprovoked seizures are medically known as epilepsy. In one implementation, the method of treating a seizure includes administering a composition that restores mitochondrial function to a seizure-genic brain region. In some embodiments, the composition can include ascorbic acid, vitamin E, and pyruvate.